Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Xangyang Shi"'
Publikováno v:
Drug Discovery Today Biosilico
Drug Discovery Today Biosilico, Elsevier, 2020, 25 (6), pp.1065-1073. ⟨10.1016/j.drudis.2020.03.009⟩
Drug Discovery Today Biosilico, Elsevier, 2020, 25 (6), pp.1065-1073. ⟨10.1016/j.drudis.2020.03.009⟩
International audience; Aptamers are RNA or DNA oligonucleotides interacting to form unique 3D target conformations with high affinity and specificity, and are emerging as a powerful class of ligands for therapeutic applications. In addition, dendrim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb12298ee9ba7e9ec89497ae6e4bc768
https://doi.org/10.1016/j.drudis.2020.03.009
https://doi.org/10.1016/j.drudis.2020.03.009
Autor:
Helena Tomás, Jean-Pierre Majoral, Serge Mignani, Xangyang Shi, Andrii Karpus, João Rodrigues
Publikováno v:
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2021, 219, pp.113456. ⟨10.1016/j.ejmech.2021.113456⟩
European Journal of Medicinal Chemistry, 2021, 219, pp.113456. ⟨10.1016/j.ejmech.2021.113456⟩
European Journal of Medicinal Chemistry, Elsevier, 2021, 219, pp.113456. ⟨10.1016/j.ejmech.2021.113456⟩
European Journal of Medicinal Chemistry, 2021, 219, pp.113456. ⟨10.1016/j.ejmech.2021.113456⟩
International audience; Research to develop active dendrimers by themselves or as nanocarriers represents a promising approach to discover new biologically active entities that can be used to tackle unmet medical needs including difficult diseases. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4d30283975cf88f84d20b8dcf57dca5
https://hal.archives-ouvertes.fr/hal-03275575
https://hal.archives-ouvertes.fr/hal-03275575
